Bringing Aberrant Proteins Back into the Fold
RARECast - Un podcast de RARECast - Les jeudis
Catégories:
Eric Richman, CEO of Gain Therapeutics, discusses its platform technology, how it works, and why it offers a compelling alternative to other approaches to treating lysosomal storage disorders.
